Treatment of haemophilia in the United Kingdom 1981–1996

This publication has 26 references indexed in Scilit:

• Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population
  The Lancet, 1996
• The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93
  British Journal of Haematology, 1995
• Confirmation of viral safety of dry heated factor VIII concentrate (8Y) prepared by Bio Products Laboratory (BPL): a report on behalf of U.K. Haemophilia Centre Directors
  British Journal of Haematology, 1993
• Recommendations on choice of therapeutic products for the treatment of patients with haemophilia A, haemophilia B and von Willebrand??s disease
  Blood Coagulation & Fibrinolysis, 1992
• Carrier testing and prenatal diagnosis for hemophilia: Experiences and attitudes of 549 potential and obligate carriers
  American Journal of Medical Genetics, 1990
• HIV Seroconversion in Haemophilic Boys Receiving Heat‐Treated Factor VIII Concentrate
  Vox Sanguinis, 1990
• Seropositivity for HIV in U.K. haemophiliacs
  Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 1989
• Prevalence of antibody to HTLV-III in haemophiliacs in the United Kingdom.
  BMJ, 1986
• Gene deletions in patients with haemophilia B and anti-factor IX antibodies
  Nature, 1983
• Jaundice and Antibodies Directed against Factors VIII and IX in Patients Treated for Haemophilia or Christmas Disease in the United Kingdom
  British Journal of Haematology, 1974